Jacobs Levy Equity Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
Jacobs Levy Equity Management's IDXX Position: Q4 2021 in Review
Jacobs Levy Equity Management sold out of Idexx Laboratories (IDXX) in Q4 2021, closing a stake of 1,343 shares — an estimated $835K sold.
Jacobs Levy Equity Management first reported a position in IDXX in Q1 2016 and held it in 20 quarters. The position peaked at $24.9M in Q3 2018. 1,106 funds tracked by Wall St. Rank hold IDXX as of Q4 2021.
- Jacobs Levy Equity Management reported no remaining Idexx Laboratories position as of Q4 2021 after selling out during the quarter.
- Jacobs Levy Equity Management sold 1,343 Idexx Laboratories shares in Q4 2021, an estimated $835K.
- Jacobs Levy Equity Management first reported a position in Idexx Laboratories in Q1 2016 and held it in 20 quarters.
- Jacobs Levy Equity Management's Idexx Laboratories position peaked at $24.9M in Q3 2018.
- 1,106 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2021.
Based on Jacobs Levy Equity Management's 13F filing for Q4 2021, filed 14 Feb 2022.